Pain Management Physician Salary Guide 2026: ESI, RFA, SCS, and Interventional Pain Income

Pain management physician salary overview 2026

Interventional pain management is a procedure-intensive subspecialty attracting physicians primarily from anesthesiology (ABPM board-certified), physical medicine and rehabilitation, and neurology — each completing a 1-year pain medicine fellowship following their base specialty training. Mean total compensation in 2026 ranges from $280,000–$450,000 in academic settings, $300,000–$500,000 in employed health system pain management programs, and $400,000–$800,000+ in private interventional pain practices — particularly those with ambulatory surgery center ownership. The specialty's income is almost entirely procedure-driven: the wRVU generated by epidural steroid injections, radiofrequency ablations, and spinal cord stimulators performed at high volume in an ASC setting is what separates the high-income pain management practice from the employed pain clinic model.

Income by practice setting

• Academic pain medicine: $280,000–$450,000; complex chronic pain conditions (CRPS, central sensitization, cancer pain); multidisciplinary pain program leadership; research in neuromodulation, novel analgesics, and pain neuroscience; fellowship training program; ACGME-accredited; lowest income but deepest clinical complexity and academic career development
• Employed health system pain management clinic: $300,000–$480,000; outpatient interventional pain services for the health system's patient population; wRVU production bonus above threshold; procedures performed at hospital-owned ASC or pain procedure suite; physician captures professional fee only; stable income with predictable call structure (most pain management is outpatient elective)
• Private interventional pain practice with ASC: $450,000–$800,000+; physician-owned or physician-partnership group; procedures performed in physician-owned ASC; captures both professional and facility fee for each procedure; significant business overhead (compliance, billing, AAAHC/JCAHO ASC accreditation, DEA compliance, KASPER/PDMP monitoring); highest income in specialty
• Large private pain group (PE-backed or multi-site): $380,000–$650,000; National Spine & Pain Centers, Integrated Pain Consultants, Remedy Pain Solutions, and regional groups; competitive base salary; productivity bonus; some groups offer ASC equity; PE consolidation growing in pain management similar to other procedure-specialties

Procedure-level billing: spinal injections

• Cervical epidural steroid injection (interlaminar): CPT 62321 (with fluoroscopic guidance); professional fee $500–$900; cervical radiculopathy, cervical disc herniation, cervical spinal stenosis; fluoroscopy required for safe needle placement at C3-C7 levels; bilateral approach billing with modifier
• Lumbar/sacral epidural steroid injection: CPT 62323 (with fluoroscopic guidance); professional fee $450–$800; lumbar radiculopathy, spinal stenosis, disc herniation, post-laminectomy syndrome; most commonly performed pain procedure nationally; bilateral or unilateral approach; CT guidance (CPT 77003) used at some programs instead of fluoroscopy
• Transforaminal epidural steroid injection (TFESI): CPT 64483 (first level) / 64484 (each additional level); professional fee $500–$900 per level; nerve root-specific delivery of corticosteroid; higher specificity than interlaminar ESI for radicular pain; bilateral or multilevel TFESI generates multiple-level billing with add-on codes
• Cervical medial branch block (MBB): CPT 64490 (first level) / 64491 (second level) / 64492 (third and each additional); professional fee $300–$600 per level; diagnostic block for cervical facet joint pain; bilateral blocks (separate codes); diagnostic blocks × 2 required before RFA eligibility by Medicare guidelines
• Lumbar medial branch block: CPT 64493 (first level) / 64494 (second level) / 64495 (each additional); professional fee $300–$600 per level; lumbar facet syndrome diagnosis; high-volume procedure; bilateral and multilevel billing common; each bilateral block set (e.g., L3, L4, L5 bilateral) generates 3–6 CPT codes simultaneously
• Intra-articular facet injection: CPT 64490–64492 (cervical) / 64493–64495 (lumbar); same codes as MBB; professional fee $300–$600 per joint; therapeutic injection vs. diagnostic block depending on documentation; fluoroscopy or CT guidance required for accurate joint entry
• Sacroiliac joint injection: CPT 27096 (with fluoroscopy); professional fee $400–$700; SI joint dysfunction and sacroiliac joint pain; bilateral injection generates bilateral modifier billing; common in post-fusion patients with adjacent joint syndrome

Procedure-level billing: radiofrequency ablation and neuromodulation

• Cervical medial branch radiofrequency ablation (RFA): CPT 64633 (first level) / 64634 (additional); professional fee $600–$1,200 per level; thermal ablation of medial branch nerves innervating cervical facet joints; durability 6–24 months; repeat RFA as nerve regenerates; high recurring revenue from same-patient repeat procedure need
• Lumbar medial branch RFA: CPT 64635 (first level) / 64636 (additional); professional fee $600–$1,200 per level; lumbar facet syndrome; bilateral lumbar RFA at L3-L5 generates 4–6 CPT codes with significant total professional fee billing; highest per-session revenue procedure in pain management at most practices
• Cooled radiofrequency ablation (CRFA) for SI joint: CPT 64640 (destructive by neurolytic agent, or by radiofrequency); professional fee $800–$1,500; sacroiliac joint pain treatment with cooled RF technology (Coolief, Nimbus); broader ablation zone than conventional RF; longer durability; growing utilization post-SI joint injection
• Genicular nerve RFA (knee): CPT 64640; professional fee $700–$1,200; knee osteoarthritis pain management; superolateral, superomedial, and inferomedial genicular nerve targets; outpatient procedure; growing utilization in patients with knee OA who are not surgical candidates or who refuse/defer TKA
• Spinal cord stimulator (SCS) trial: CPT 63650 (percutaneous electrode placement, trial); professional fee $1,500–$3,000; 7–10 day trial with external pulse generator; chronic low back pain, failed back surgery syndrome, CRPS, peripheral vascular disease pain; trial determines permanent implant candidacy
• SCS permanent implant: CPT 63685 (receiver + pulse generator implant) + 63650; professional fee $3,500–$6,000; permanent subcutaneous IPG (Abbott, Medtronic, Boston Scientific, Nevro HF10); programming visits (CPT 95971/95972) generate follow-up billing; next-generation closed-loop and high-frequency SCS devices growing
• Intrathecal drug delivery system (IDDS) implant: CPT 62362 (implant) + 62350 (catheter); professional fee $4,000–$7,000; intrathecal morphine or ziconotide pump for chronic intractable pain, cancer pain, or spasticity; refill visits (CPT 95990/95991) recurring every 2–4 months depending on concentration; highest-complexity and highest-value implant in pain management
• Peripheral nerve stimulation (PNS): CPT 64555 (trial) / 64580 (implant); growing indication for occipital neuralgia (ONS), peripheral neuropathy, and complex regional pain; Bioness StimRouter, Nalu, Saluda platforms; high-growth procedure category in pain management

Other pain management billing

• Botulinum toxin injections (OnabotulinumtoxinA / Botox for chronic migraine): CPT 64615 (chemodenervation, head/neck muscles for migraine); J-code J0585; professional fee $300–$600; drug cost $1,000–$2,000/treatment at WAC; ASP buy-and-bill margin $200–$600/treatment at physician office acquisition; quarterly treatment cycle for chronic migraine prevention; recurring revenue from same patients
• Celiac plexus block: CPT 64530 (celiac plexus injection); professional fee $600–$1,200; pancreatic cancer pain management; CT-guided or fluoroscopic bilateral plexus injection; neurolytic (alcohol) block for definitive cancer pain management
• Trigger point injections: CPT 20552 (1–2 muscles) / 20553 (3+ muscles); professional fee $150–$350; myofascial pain syndrome; high-volume, quick office procedure often combined with E&M billing at the same visit
• Joint injections (hip, shoulder, knee — corticosteroid): CPT 20610 (major joint) + CPT 76942 (US guidance add-on); professional fee $250–$500; adjunct to pain management protocols; corticosteroid or hyaluronic acid injection for OA and bursitis
• Ketamine infusion: CPT 96365 (therapeutic drug infusion, first hour); professional fee $200–$500/session; CRPS and refractory depression; subanesthetic ketamine (0.5 mg/kg) series; not FDA-approved for chronic pain specifically but widely used off-label; cash-pay or out-of-network billing in most practices

ASC pain management economics

Ambulatory surgery center economics are the single largest income amplifier in interventional pain management. An ESI performed at a hospital or pain clinic generates a professional fee of $600–$900 and the institution captures the technical fee ($500–$1,500). The same ESI performed in a physician-owned ASC generates the same professional fee plus a facility technical fee of $500–$1,500 — effectively doubling the per-procedure economic yield. A pain management physician performing 15 procedures/day (mix of ESI, MBB, RFA, and SCS programming) 4 days/week × 50 weeks at a physician-owned ASC generates $2,000,000–$4,000,000 in total (professional + technical) annual revenue. After ASC overhead and physician group expenses, the physician owner captures $500,000–$1,200,000+ net income — the basis of the large income gap between employed and private pain management physicians.

Geographic variation in pain management compensation

• Major academic and academic-affiliated pain programs: $300,000–$470,000; complex CRPS, neuromodulation research, intrathecal therapy; fellowship training; multidisciplinary pain model; lowest income but PSLF eligible and research infrastructure access
• Sun Belt private pain markets (FL, TX, AZ, GA): $500,000–$900,000; highest private pain practice density; aging population with high musculoskeletal and spinal pain burden; FL and TX have active ASC pain markets; warm climate and large retiree population drives chronic pain demand year-round
• Midwest and Southeast employed programs: $320,000–$500,000; health system employed dominant; wRVU production bonus; hospital-owned ASC or pain procedure suite; lower income than private but lower business risk and no capital investment required

What we see at Ava Health

Pain management is one of the clearest examples in medicine where the employment model and the private practice model operate at fundamentally different income levels for the same clinical work — and where the gap is widening as ASC consolidation creates a larger share of procedure volume in physician-owned facilities. Pain management physicians in our network who are evaluating their career trajectory increasingly describe the first 5 years as the critical window: joining the right practice (one with real ASC equity, not just a future promise) in the first attending position sets the trajectory far more than the base salary offer. For hospitals recruiting pain management physicians, the competition with private practice is most acute in markets where private pain ASCs are well-established — and where the hospital's employed model is not structured to offer any ASC participation rights, the recruitment is at a systematic disadvantage that compensation alone cannot fully overcome.

Related: PM&R Physiatrist Salary Guide, Anesthesiologist Salary Guide, Neurologist Salary Guide, Spine Surgeon Salary Guide.